Beyond the lab: immuno-oncology
Read this in-depth analyses and insights from leading experts in the field focusing on treatments, new technologies and engineered bacteria.
List view / Grid view
Read this in-depth analyses and insights from leading experts in the field focusing on treatments, new technologies and engineered bacteria.
The new study’s findings suggest that CRS can be treated with an IL-6 receptor antibody that has a short half-life.
Listen to this podcast where we dive into genetic engineering, its role and relationship with allogeneic immunotherapy.
DNA vaccine optimised to cross-react with several MAGE-A isoforms generates a robust immune response and antitumour activity in a pre-clinical model of melanoma...
A gene that's associated with an autoimmune form of hair loss could be exploited to improve cancer immunotherapy...